The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States FDA Industry Systems (FIS) was created to facilitate making submissions to the U.S. Food and Drug Administration (FDA), including registrations, listings, and other notifications.
This online reference for CFR Title 21 is updated once a year. * Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not include information about FDA-approved products regulated by the Center for Biologics Evaluation and Research (for example, vaccines, allergenic products, blood and blood products, plasma derivatives, cellular and gene therapy products).
U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Contact FDA This information is current as of April 1, 2019.. For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).. FIS has been available 24 hours a day, seven days a week, since October 16, 2003 6:00 p.m. EDT. This database includes a codification of the general and permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government. U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Contact FDA